Venturi Cardiology and Caristo Diagnostics Introduce AI-Enabled Heart Disease Diagnosis and Prevention Technology in North West England

Caristo Diagnostics England United Kingdom

is a portfolio of healthcare companies based in the United Kingdom. Our companies are all connected by a common purpose – to supply specialist outpatient pathways and diagnostic imaging services. With over 20 years of experience and a national footprint, DHC Group delivers market-leading services tailored to clients' needs across the public and private healthcare sectors. Our areas of expertise include Radiology (mobile / relocatable, CDCs and static sites), Cardiology and Dental imaging.

About Caristo Diagnostics

Caristo Diagnostics is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of Oxford, the world's #1 research university, Caristo has developed a portfolio of imaging-based and AI-assisted platforms that can be applied to aid the prediction and diagnosis of heart attack, stroke, and diabetes. Caristo has been recognized by Newsweek as one of the best digital health companies, and highlighted by Nature as one of the most exciting science-based companies to have emerged from academic labs. Find Caristo online on its website, LinkedIn and X.

 

Logo: https://mma.prnewswire.com/media/2054669/Caristo.jpg
Logo: https://mma.prnewswire.com/media/2508508/4918452/Venturi.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/venturi-cardiology-and-caristo-diagnostics-introduce-ai-enabled-heart-disease-diagnosis-and-prevention-technology-in-north-west-england-302251761.html